The feasibility of an innovative GP-physiotherapist partnership to identify and manage chronic obstructive pulmonary disease (INTEGRATED): study protocol.
COPD
Physical activity
Physiotherapy/physical therapy
Primary care
Pulmonary rehabilitation
Screening
Journal
Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536
Informations de publication
Date de publication:
2020
2020
Historique:
received:
02
01
2020
accepted:
08
09
2020
entrez:
28
9
2020
pubmed:
29
9
2020
medline:
29
9
2020
Statut:
epublish
Résumé
Chronic obstructive pulmonary disease (COPD) contributes significantly to mortality, hospitalisations and health care costs worldwide. There is evidence that the detection, accurate diagnosis and management of COPD are currently suboptimal in primary care. Physiotherapists are well-trained in cardiorespiratory management and chronic care but are currently underutilised in primary care. A cardiorespiratory physiotherapist working in partnership with general practitioners (GPs) has the potential to improve quality of care for people with COPD. A prospective pilot study will test the feasibility of an integrated model of care between GPs and physiotherapists to improve the diagnosis and management of people with COPD in primary care. Four general practices will be selected to work in partnership with four physiotherapists from their local health district. Patients at risk of developing COPD or those with a current diagnosis of COPD will be invited to attend a baseline assessment with the physiotherapist, including pre- and post-bronchodilator spirometry to identify new cases of COPD or confirm a current diagnosis and stage of COPD. The intervention for those with COPD will involve the physiotherapist and GP working in partnership to develop and implement a care plan involving the following tailored to patient need: referral to pulmonary rehabilitation (PR), physical activity counselling, medication review, smoking cessation, review of inhaler technique and education. Process outcomes will include the number of people invited and reviewed at the practice, the proportion with a new diagnosis of COPD, the number of patients eligible and referred to PR and the number who attended PR. Patient outcomes will include changes in symptoms, physical activity levels, smoking status and self-reported exacerbations. If feasible, we will test the integration of physiotherapists within the primary care setting in a cluster randomised controlled trial. If the model improves health outcomes for the growing numbers of people with COPD, then it may provide a GP-physiotherapist model of care that could be tested for other chronic conditions. ANZCTR, ACTRN12619001127190. Registered on 12 August 2019-retrospectively registered.
Sections du résumé
BACKGROUND
BACKGROUND
Chronic obstructive pulmonary disease (COPD) contributes significantly to mortality, hospitalisations and health care costs worldwide. There is evidence that the detection, accurate diagnosis and management of COPD are currently suboptimal in primary care. Physiotherapists are well-trained in cardiorespiratory management and chronic care but are currently underutilised in primary care. A cardiorespiratory physiotherapist working in partnership with general practitioners (GPs) has the potential to improve quality of care for people with COPD.
METHODS
METHODS
A prospective pilot study will test the feasibility of an integrated model of care between GPs and physiotherapists to improve the diagnosis and management of people with COPD in primary care. Four general practices will be selected to work in partnership with four physiotherapists from their local health district. Patients at risk of developing COPD or those with a current diagnosis of COPD will be invited to attend a baseline assessment with the physiotherapist, including pre- and post-bronchodilator spirometry to identify new cases of COPD or confirm a current diagnosis and stage of COPD. The intervention for those with COPD will involve the physiotherapist and GP working in partnership to develop and implement a care plan involving the following tailored to patient need: referral to pulmonary rehabilitation (PR), physical activity counselling, medication review, smoking cessation, review of inhaler technique and education. Process outcomes will include the number of people invited and reviewed at the practice, the proportion with a new diagnosis of COPD, the number of patients eligible and referred to PR and the number who attended PR. Patient outcomes will include changes in symptoms, physical activity levels, smoking status and self-reported exacerbations.
DISCUSSION
CONCLUSIONS
If feasible, we will test the integration of physiotherapists within the primary care setting in a cluster randomised controlled trial. If the model improves health outcomes for the growing numbers of people with COPD, then it may provide a GP-physiotherapist model of care that could be tested for other chronic conditions.
TRIAL REGISTRATION
BACKGROUND
ANZCTR, ACTRN12619001127190. Registered on 12 August 2019-retrospectively registered.
Identifiants
pubmed: 32983555
doi: 10.1186/s40814-020-00680-4
pii: 680
pmc: PMC7513496
doi:
Types de publication
Journal Article
Langues
eng
Pagination
138Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare that they have no competing interests.
Références
Thorax. 2008 May;63(5):408-14
pubmed: 18024537
Fam Pract. 2016 Dec;33(6):663-670
pubmed: 27535327
Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65
pubmed: 22878278
Am J Respir Crit Care Med. 2005 Jul 1;172(1):19-38
pubmed: 15778487
Chest. 1988 Mar;93(3):580-6
pubmed: 3342669
Can Respir J. 2008 Jan-Feb;15(1):13-9
pubmed: 18292848
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Med J Aust. 2013 Feb 18;198(3):144-8
pubmed: 23418694
Eur Respir J. 2019 Apr 25;53(4):
pubmed: 30792342
Health Serv Res. 2005 Dec;40(6 Pt 1):1918-30
pubmed: 16336556
Physiotherapy. 2012 Jun;98(2):131-7
pubmed: 22507363
Med J Aust. 2001 Jul 16;175(2):95-8
pubmed: 11556428
Breathe (Sheff). 2019 Jun;15(2):110-115
pubmed: 31191721
Med J Aust. 2017 Nov 20;207(10):436-442
pubmed: 29129177
BMJ. 2014 Sep 10;349:g5392
pubmed: 25209620
Lancet Respir Med. 2014 Mar;2(3):195-203
pubmed: 24621681
Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26
pubmed: 15230939
Scand J Caring Sci. 2016 Sep;30(3):432-41
pubmed: 26426088
Med Care. 1999 Jan;37(1):5-14
pubmed: 10413387
Chest. 2007 May;131(5 Suppl):4S-42S
pubmed: 17494825
Med J Aust. 2012 Oct 1;197(7):394-8
pubmed: 23025736
Respir Med. 2012 Mar;106(3):374-81
pubmed: 22000501
Cochrane Database Syst Rev. 2015 Feb 23;(2):CD003793
pubmed: 25705944
Chest. 2006 Jun;129(6):1531-9
pubmed: 16778271
J Gen Intern Med. 2011 Nov;26(11):1272-7
pubmed: 21713542
Prim Care Respir J. 2009 Sep;18(3):171-6
pubmed: 19142557
Physiother Can. 2010 Fall;62(4):368-73
pubmed: 21886377
Cochrane Database Syst Rev. 2013 Oct 10;(10):CD009437
pubmed: 24108523
Am J Med. 2008 May;121(5):433-443.e4
pubmed: 18456040
Fam Pract. 2017 Aug 1;34(4):485-490
pubmed: 27694575
Med J Aust. 2005 Jul 18;183(2):64-7
pubmed: 16022608
Health Psychol. 1992;11(6):386-95
pubmed: 1286658
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986
Implement Sci. 2012 Sep 07;7:83
pubmed: 22958678
Respir Med. 2007 Aug;101(8):1753-60
pubmed: 17448651
Prim Health Care Res Dev. 2016 Sep;17(5):489-502
pubmed: 27263326
Eur Respir J. 2009 Sep;34(3):648-54
pubmed: 19720809
Intern Med J. 2011 Mar;41(3):263-70
pubmed: 20002857
Int J Chron Obstruct Pulmon Dis. 2011;6:659-67
pubmed: 22259242
Aust Fam Physician. 2009 Oct;38(10):826-30
pubmed: 19893824
BMJ. 2002 Jun 8;324(7350):1370
pubmed: 12052807
NPJ Prim Care Respir Med. 2016 Sep 29;26:16059
pubmed: 27684728
Respir Med. 2018 Apr;137:103-114
pubmed: 29605192